ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS

This study is ongoing, but not recruiting participants.
Study NCT00439673.   Last updated on November 7, 2008.   Information provided by Gruppo Italiano Malattie EMatologiche dell'Adulto

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Myelodysplastic Syndromes
2 Additional conditions recognized in this trial
Preleukemia
Syndrome
3 More general conditions related to this trial
Bone Marrow Diseases
Disease
Hematologic Diseases
Neoplasms
Pathologic Processes
Precancerous Conditions
4 Interventions listed in this trial
5-Azacytidine
Valproic Acid
ATRA
5 Additional drug interventions recognized in this trial
Azacitidine
6 More general drug interventions related to this trial
Anticonvulsants
Antimanic Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Central Nervous System Agents
Central Nervous System Depressants
Enzyme Inhibitors
GABA Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
7 Sponsors listed in this trial
Gruppo Italiano Malattie EMatologiche dell'Adulto




Links to all studies - primarily for crawlers